HOME
SEARCH
RSS FEED
SUBSCRIBE
Brother of the Regulator of Imprinted Sites (BORIS)
Case ID:
TAB-860
Web Published:
12/6/2022
Description:
The subject application discloses an isolated or purified nucleic acid molecule consisting essentially of a nucleotide sequence encoding a human or a non-human BORIS, or a fragment of either of the foregoing; an isolated or purified nucleic acid molecule consisting essentially of a nucleotide sequence that is complementary to a nucleotide sequence encoding a human or a non-human BORIS, or a fragment of either of the following; a vector comprising such an isolated or purified polypeptide molecule consisting essentially of an amino acid sequence encoding a human or a non-human BORIS, or a fragment or either of the foregoing; a cell line that produces a monoclonal antibody that is specific for an aforementioned isolated or purified polypeptide molecule; and the monoclonal antibody produced by the cell line; methods of diagnosing a cancer or a predisposition to a cancer in a male or female mammal; a method of prognosticating a cancer in a mammal; a method of assessing the effectiveness of treatment of a cancer in a mammal; a method of treating a mammal prophylactically or therapeutically for a cancer; and a composition comprising a carrier and an inhibitor of BORIS.
Patent Information:
Title
App Type
Country
Serial No.
Patent No.
File Date
Issued Date
Expire Date
Patent Status
Direct Link:
https://nih.technologypublisher.com/tech/Brother_of_the_Regulator_of_Imprinte d_Sites_(BORIS)
Category(s):
Licensing
Oncology
Diagnostics
Bookmark this page
Download as PDF
For Information, Contact:
Dawn Taylor-Mulneix
TTPS
NIH Technology Transfer
301-761-6958
dawn.taylor-mulneix@nih.gov
Inventors:
Victor Lobanenkov
Keywords:
CA1AXX
CA1CXX
CAXXXX
CXXXXX
Home
|
Search
|
RSS
|
Subscribe
© 2025. All Rights Reserved. Powered by
Inteum